Biorce

Investments

Biorce closes $52.5 million Series A to accelerate international expansion and lead the transformation of clinical trials through AI

Biorce, a Barcelona-based health AI company specialized in applying artificial intelligence to the design and execution of clinical trials, has closed a $52.5 million Series A round. The financing includes new investment from DST Global Partners, with existing investors Norrsken VC and YZR Capital increasing their participation, alongside participation from Mustard Seed Maze and Endeavor […]

Investments

Biorce raises €5M to accelerate drug development with AI

sradmin

Barcelona-based healthtech startup Biorce received €5 million in investment from Norrsken VC, Europe’s largest impact VC. The funding comes just seven months after Biorce’s €3.5 million first round in November 2024, led by healthtech specialist YZR Capital and Mustard Seed Maze. Clinical trials are essential for advancing new treatments, but the process often faces delays. […]

Cookie	Type	Duration	Description
__cfduid	third party	1 year	Used by the contentn etwork, Cloudflare, to identify trusted web traffic.
_ga	third party	2 years	Registers a uniqu e ID that is used to generate statistical data on how the visitor uses the website.
woocommerce_cart_hash	session	session	e-Commerce temporary session
woocommerce_items_in_cart	session	session	e-Commerce temporary session
wp_woocommerce_session_	session	session	e-Commerce temporary session

Biorce

Biorce closes $52.5 million Series A to accelerate international expansion and lead the transformation of clinical trials through AI

Biorce raises €5M to accelerate drug development with AI

This website uses cookies